http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2511291-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_474e284e10e4cc7ffe566f2ca951b1d0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56927 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-295 |
| filingDate | 2008-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_271d72fb49a094d3224162bc33b419ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0198afa39355a74f769e0f76449e8b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928e036c13d68fcac02e6b476463869d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413325fc8285e43854d0abce21ba86ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4299e8eb4aacb4b29ca219c3d32ba4 |
| publicationDate | 2012-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2511291-A2 |
| titleOfInvention | Chlamydia antigens |
| abstract | The present invention relates to isolated nucleic acid molecules which encode an antigen from a Chlamydia species, a vector which comprises such nucleic acid molecule, and a host cell comprising such vector. Furthermore, the invention provides antigens from a Chlamydia species, as well as fragments and variants thereof, a process for producing such antigens, and a process for producing a cell, which expresses such antigen. More specifically such antigens are produced by or associated with bacterial infections caused by Chlamydia pneumoniae. Moreover, the present invention provides antibodies binding to such antigen, a hybridoma cell producing such antibodies, methods for producing such antibodies, a pharmaceutical composition comprising such nucleic acid molecule, antigen, vector or antibody, the use of such nucleic acid molecule, antigen, vector or antibody for the preparation of a pharmaceutical composition, methods for identifying an antagonist capable of binding such antigen or of reducing or inhibiting the interaction activity of such antigen, methods for diagnosing an infection with Chlamydia and methods for the treatment or prevention of an infection with Chlamydia. |
| priorityDate | 2007-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 457.